Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD Cohort

<b>Background:</b> The aim of this study was to investigate the accuracy in fibrosis staging of a novel shear wave elastography (SWE) device (S-Shearwave Imaging by Samsung) and a previously validated 2D-SWE by Supersonic Imagine (SSI) in patients with biopsy proven metabolic dysfunction...

Full description

Saved in:
Bibliographic Details
Main Authors: Antonio Liguori, Giorgio Esposto, Maria Elena Ainora, Irene Mignini, Raffaele Borriello, Linda Galasso, Mattia Paratore, Maria Cristina Giustiniani, Laura Riccardi, Matteo Garcovich, Antonio Gasbarrini, Luca Miele, Maria Assunta Zocco
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/13/1/138
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588986446512128
author Antonio Liguori
Giorgio Esposto
Maria Elena Ainora
Irene Mignini
Raffaele Borriello
Linda Galasso
Mattia Paratore
Maria Cristina Giustiniani
Laura Riccardi
Matteo Garcovich
Antonio Gasbarrini
Luca Miele
Maria Assunta Zocco
author_facet Antonio Liguori
Giorgio Esposto
Maria Elena Ainora
Irene Mignini
Raffaele Borriello
Linda Galasso
Mattia Paratore
Maria Cristina Giustiniani
Laura Riccardi
Matteo Garcovich
Antonio Gasbarrini
Luca Miele
Maria Assunta Zocco
author_sort Antonio Liguori
collection DOAJ
description <b>Background:</b> The aim of this study was to investigate the accuracy in fibrosis staging of a novel shear wave elastography (SWE) device (S-Shearwave Imaging by Samsung) and a previously validated 2D-SWE by Supersonic Imagine (SSI) in patients with biopsy proven metabolic dysfunction-associated steatotic liver disease (MASLD). <b>Methods:</b> This prospective study included 75 consecutive patients with MASLD who underwent liver biopsy for suspected MASH. All patients underwent S-Shearwave Imaging by Samsung and 2D-SWE with SSI on the same day of liver biopsy. Fibrosis was histologically assessed using the METAVIR classification system. Agreement between the equipment was assessed with the Pearson coefficient. A receiver operator characteristic curve (ROC) analysis with the Youden index was used to establish thresholds for fibrosis staging. <b>Results:</b> A good correlation was found between S-Shearwave Imaging by Samsung and 2D-SWE with SSI (Pearson’s R = 0.68; <i>p</i> < 0.01). At multivariate regression analysis, S-Shearwave Imaging was associated with advanced fibrosis (≥F3) independently from age, diabetes and platelets (OR 2.94, CI 1.69–5.11, <i>p</i> < 0.01). The fibrosis diagnostic accuracy of both S-Shearwave Imaging and 2D-SWE was good to optimal with AUROCs of 0.81 and 0.70 for significant fibrosis (≥F2), 0.94 and 0.91 for severe fibrosis (≥F3), respectively. The accuracy of S-Shearwave is not significantly different from Fibroscan and Agile3+ (DeLong test <i>p</i> value 0.16 and 0.15, respectively) while is slightly better than 2D-SWE, FIB4 and NFS (DeLong test <i>p</i> value < 0.05). For S-Shearwave Imaging by Samsung, the best cut-off values for diagnosing fibrosis ≥F2, ≥F3 were, respectively, 7.9 kPa (Sens 74.4%, Spec 87.5%) and 8.1 kPa (Sens 95.6%, Spec 78.8%). For 2D-SWE by SSI, the best cut-off values for diagnosing fibrosis ≥F2, ≥F3 were, respectively, 7.2 kPa (Sens 55.8%, Spec 84.4%) and 7.6 kPa (Sens 82.6%, Spec 84.6%). <b>Conclusion:</b> S-Shearwave Imaging is a useful and reliable non-invasive technique for staging liver fibrosis in patients with MASLD. Its diagnostic accuracy is non-inferior to other shear wave elastography techniques (TE and 2D-SWE by SSI).
format Article
id doaj-art-8475f0a2314a49699e0f166fd6005448
institution Kabale University
issn 2227-9059
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj-art-8475f0a2314a49699e0f166fd60054482025-01-24T13:24:08ZengMDPI AGBiomedicines2227-90592025-01-0113113810.3390/biomedicines13010138Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD CohortAntonio Liguori0Giorgio Esposto1Maria Elena Ainora2Irene Mignini3Raffaele Borriello4Linda Galasso5Mattia Paratore6Maria Cristina Giustiniani7Laura Riccardi8Matteo Garcovich9Antonio Gasbarrini10Luca Miele11Maria Assunta Zocco12Centro Malattie Apparato Digerente—CEMAD, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Roma, ItalyCentro Malattie Apparato Digerente—CEMAD, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Roma, ItalyCentro Malattie Apparato Digerente—CEMAD, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Roma, ItalyCentro Malattie Apparato Digerente—CEMAD, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Roma, ItalyCentro Malattie Apparato Digerente—CEMAD, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Roma, ItalyCentro Malattie Apparato Digerente—CEMAD, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Roma, ItalyCentro Malattie Apparato Digerente—CEMAD, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Roma, ItalyDipartimento di Scienze Della Salute Della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Roma, ItalyCentro Malattie Apparato Digerente—CEMAD, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Roma, ItalyCentro Malattie Apparato Digerente—CEMAD, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Roma, ItalyCentro Malattie Apparato Digerente—CEMAD, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Roma, ItalyCentro Malattie Apparato Digerente—CEMAD, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Roma, ItalyCentro Malattie Apparato Digerente—CEMAD, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Roma, Italy<b>Background:</b> The aim of this study was to investigate the accuracy in fibrosis staging of a novel shear wave elastography (SWE) device (S-Shearwave Imaging by Samsung) and a previously validated 2D-SWE by Supersonic Imagine (SSI) in patients with biopsy proven metabolic dysfunction-associated steatotic liver disease (MASLD). <b>Methods:</b> This prospective study included 75 consecutive patients with MASLD who underwent liver biopsy for suspected MASH. All patients underwent S-Shearwave Imaging by Samsung and 2D-SWE with SSI on the same day of liver biopsy. Fibrosis was histologically assessed using the METAVIR classification system. Agreement between the equipment was assessed with the Pearson coefficient. A receiver operator characteristic curve (ROC) analysis with the Youden index was used to establish thresholds for fibrosis staging. <b>Results:</b> A good correlation was found between S-Shearwave Imaging by Samsung and 2D-SWE with SSI (Pearson’s R = 0.68; <i>p</i> < 0.01). At multivariate regression analysis, S-Shearwave Imaging was associated with advanced fibrosis (≥F3) independently from age, diabetes and platelets (OR 2.94, CI 1.69–5.11, <i>p</i> < 0.01). The fibrosis diagnostic accuracy of both S-Shearwave Imaging and 2D-SWE was good to optimal with AUROCs of 0.81 and 0.70 for significant fibrosis (≥F2), 0.94 and 0.91 for severe fibrosis (≥F3), respectively. The accuracy of S-Shearwave is not significantly different from Fibroscan and Agile3+ (DeLong test <i>p</i> value 0.16 and 0.15, respectively) while is slightly better than 2D-SWE, FIB4 and NFS (DeLong test <i>p</i> value < 0.05). For S-Shearwave Imaging by Samsung, the best cut-off values for diagnosing fibrosis ≥F2, ≥F3 were, respectively, 7.9 kPa (Sens 74.4%, Spec 87.5%) and 8.1 kPa (Sens 95.6%, Spec 78.8%). For 2D-SWE by SSI, the best cut-off values for diagnosing fibrosis ≥F2, ≥F3 were, respectively, 7.2 kPa (Sens 55.8%, Spec 84.4%) and 7.6 kPa (Sens 82.6%, Spec 84.6%). <b>Conclusion:</b> S-Shearwave Imaging is a useful and reliable non-invasive technique for staging liver fibrosis in patients with MASLD. Its diagnostic accuracy is non-inferior to other shear wave elastography techniques (TE and 2D-SWE by SSI).https://www.mdpi.com/2227-9059/13/1/138SWEShearwave elastographyliver fibrosisMASLD
spellingShingle Antonio Liguori
Giorgio Esposto
Maria Elena Ainora
Irene Mignini
Raffaele Borriello
Linda Galasso
Mattia Paratore
Maria Cristina Giustiniani
Laura Riccardi
Matteo Garcovich
Antonio Gasbarrini
Luca Miele
Maria Assunta Zocco
Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD Cohort
Biomedicines
SWE
Shearwave elastography
liver fibrosis
MASLD
title Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD Cohort
title_full Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD Cohort
title_fullStr Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD Cohort
title_full_unstemmed Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD Cohort
title_short Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD Cohort
title_sort liver elastography for liver fibrosis stratification a comparison of three techniques in a biopsy controlled masld cohort
topic SWE
Shearwave elastography
liver fibrosis
MASLD
url https://www.mdpi.com/2227-9059/13/1/138
work_keys_str_mv AT antonioliguori liverelastographyforliverfibrosisstratificationacomparisonofthreetechniquesinabiopsycontrolledmasldcohort
AT giorgioesposto liverelastographyforliverfibrosisstratificationacomparisonofthreetechniquesinabiopsycontrolledmasldcohort
AT mariaelenaainora liverelastographyforliverfibrosisstratificationacomparisonofthreetechniquesinabiopsycontrolledmasldcohort
AT irenemignini liverelastographyforliverfibrosisstratificationacomparisonofthreetechniquesinabiopsycontrolledmasldcohort
AT raffaeleborriello liverelastographyforliverfibrosisstratificationacomparisonofthreetechniquesinabiopsycontrolledmasldcohort
AT lindagalasso liverelastographyforliverfibrosisstratificationacomparisonofthreetechniquesinabiopsycontrolledmasldcohort
AT mattiaparatore liverelastographyforliverfibrosisstratificationacomparisonofthreetechniquesinabiopsycontrolledmasldcohort
AT mariacristinagiustiniani liverelastographyforliverfibrosisstratificationacomparisonofthreetechniquesinabiopsycontrolledmasldcohort
AT laurariccardi liverelastographyforliverfibrosisstratificationacomparisonofthreetechniquesinabiopsycontrolledmasldcohort
AT matteogarcovich liverelastographyforliverfibrosisstratificationacomparisonofthreetechniquesinabiopsycontrolledmasldcohort
AT antoniogasbarrini liverelastographyforliverfibrosisstratificationacomparisonofthreetechniquesinabiopsycontrolledmasldcohort
AT lucamiele liverelastographyforliverfibrosisstratificationacomparisonofthreetechniquesinabiopsycontrolledmasldcohort
AT mariaassuntazocco liverelastographyforliverfibrosisstratificationacomparisonofthreetechniquesinabiopsycontrolledmasldcohort